Tumour-associated macrophages targeted transfection with NF-κB decoy/mannose-modified bubble lipoplexes inhibits tumour growth in tumour-bearing mice

References

• Lee HW, Choi HJ, Ha SJ, et al. Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim Biophys Acta 2013;1835:170–9
   PubMed Web of Science ®Google Scholar
• Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012;33:119–26
   PubMed Web of Science ®Google Scholar
• Mantovani A, Schioppa T, Porta C, et al. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006;25:315–22
   PubMed Web of Science ®Google Scholar
• Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71–8
   PubMed Web of Science ®Google Scholar
• Siveen KS, Kuttan G. Role of macrophages in tumour progression. Immunol Lett 2009;123:97–102
   PubMed Web of Science ®Google Scholar
• Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. Scientific World Journal 2011;11:2391–402
   Google Scholar
• Mosser DM. The many faces of macrophages activation. J Leukoc Biol 2003;73:209–12
   PubMed Web of Science ®Google Scholar
• Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23–35
   PubMed Web of Science ®Google Scholar
• Sica A, Schioppa T, Mantovni A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717–27
   PubMed Web of Science ®Google Scholar
• Coscia M, Quaglino E, Iezzi M, et al. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med 2010;14:2803–15
   PubMed Web of Science ®Google Scholar
• Hagemann T, Lawrence T, McNeish I, et al. “Re-educating” tumor-associated macrophages by targeting NF-κB. J Exp Med 2008;205:1261–8
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Nakatsuji M, Seno H, et al. COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis 2011;32:1333–9
   PubMed Web of Science ®Google Scholar
• Biswas SK, Lewis CE. NF-κB as a central regulator of macrophage function in tumors. J Leukoc Biol 2010;88:877–84
   PubMed Web of Science ®Google Scholar
• Mancino A, Lawrence T. Nuclear factor-κB and tumor-associated macrophages. Clin Cancer Res 2010;16:784–9
   PubMed Web of Science ®Google Scholar
• Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proc Natl Acad Sci USA 2009;106:14978–83
   PubMed Web of Science ®Google Scholar
• Saccani A, Schioppa T, Porta T, et al. p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006;66:11432–40
   PubMed Web of Science ®Google Scholar
• Morishita R, Tomita N, Kaneda Y, Ogihara T. Molecular therapy to inhibit NFκB activation by transcription factor decoy oligonucleotides. Curr Opin Pharmacol 2004;4:139–46
   PubMed Web of Science ®Google Scholar
• Wijagkanalan W, Kawakami S, Higuchi Y, et al. Intracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation. J Control Release 2011;149:42–50
   PubMed Web of Science ®Google Scholar
• Cieslewicz M, Tang J, Yu JL, et al. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci USA 2013;110:15919–24
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhang Z, Jiang Y, et al. Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. J Control Release 2012;158:286–92
   PubMed Web of Science ®Google Scholar
• Zhu S, Niu M, O’Mary H, Cui Z. Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol Pharm 2013;10:3525–30
   Google Scholar
• Un K, Kawakami S, Yoshida M, et al. Efficient suppression of murine intracellular adhesion molecule-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation. Hepatology 2012;56:259–69
   PubMed Web of Science ®Google Scholar
• Allavena P, Chieppa M, Bianchi G, et al. Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol 2010;2010:547179
   PubMedGoogle Scholar
• Hagemann T, Wilson J, Burke F, et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 2006;176:5023–32
   PubMed Web of Science ®Google Scholar
• Un K, Kawakami S, Suzuki R, et al. Development of ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials 2010;31:7813–26
   PubMed Web of Science ®Google Scholar
• De Stefano D. Oligonucleotides decoy to NF-kappaB: becoming a reality? Discov Med 2011;12:97–105
   PubMed Web of Science ®Google Scholar
• Egashira K, Suzuki J, Ito H, et al. Long-term follow up of initial clinical cases with NF-κB decoy oligodeoxynucleotide transfection at the site of coronary stenting. J Gene Med 2008;10:805–9
   PubMed Web of Science ®Google Scholar
• Suzuki J, Tezuka D, Morishita R, Isobe M. An initial case of suppressed restenosis with nuclear factor-kappa B decoy transfection after percutaneous coronary intervention. J Gene Med 2009;11:89–91
   PubMed Web of Science ®Google Scholar
• Higuchi Y, Nishikawa M, Kawakami S, et al. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells. Int J Pharm 2004;287:147–54
   PubMed Web of Science ®Google Scholar
• Dinh TD, Higuchi Y, Kawakami S, et al. Evaluation of osteoclastogenesis via NFκB decoy/mannosylated cationic liposome-mediated inhibition of pro-inflammatory cytokine production from primary cultured macrophages. Pharm Res 2011;28:742–51
   PubMed Web of Science ®Google Scholar
• Hattori Y, Kawakami S, Nakamura K, et al. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J pharmacol Exp Ther 2006;318:828–34
   PubMed Web of Science ®Google Scholar
• Kawakami S, Sato A, Nishikawa M, et al. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 2000;7:292–9
   PubMed Web of Science ®Google Scholar
• Lu CT, Zhao YZ, Wu Y, et al. Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles. Cancer Chemother Pharmacol 2011;68:343–8
   PubMed Web of Science ®Google Scholar
• Suzuki R, Namai E, Oda Y, et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles tumoral ultrasound exposure. J Control Release 2010;142:245–50
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Lu CT, Zhou ZC, et al. Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment. J Drug Target 2011;19:154–60
   PubMed Web of Science ®Google Scholar
• Suzuki R, Takizawa T, Negishi Y, et al. Effective gene delivery with liposomal bubbles and ultrasound as novel non-viral system. J Drug Target 2007;15:531–7
   PubMed Web of Science ®Google Scholar
• Un K, Kawakami S, Suzuki R, et al. Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum Gene Ther 2010;21:65–74
   PubMed Web of Science ®Google Scholar
• Un K, Kawakami S, Yoshida M, et al. The elucidation of gene transferring mechanism by ultrasound-responsive and unmodified and mannose-modified lipoplexes. Biomaterials 2011;32:4659–69
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:579–55
   Google Scholar
• Massi D, Marconi C, Franchi A, et al. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. Hum Pathol 2007;38:1516–25
   PubMed Web of Science ®Google Scholar
• Pettersen JS, Fuentes-Duculan J, Suárez-Fariñas M, et al. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol 2011;131:1322–30
   PubMed Web of Science ®Google Scholar
• Wu H, Xu JB, He YL, et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol 2012;106:462–8
   PubMed Web of Science ®Google Scholar
• Kawamura I, Morishita R, Tomita N, et al. Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model. Gene Ther 1999;6:91–7
   PubMed Web of Science ®Google Scholar
• Kono Y, Kawakami S, Higuchi Y, et al. In vitro evaluation of inhibitory effect of NF-κB activity by siRNA on pro-tumor characteristics of M2-like macrophages. Biol Pharm Bull 2014;37:137–44
   Google Scholar
• Un K, Kawakami S, Higuchi Y, et al. Involvement of activated transcriptional process in efficient gene transfection using unmodified and mannose-modified bubble lipoplexes with ultrasound exposure. J Control Release 2011;156:355–63
   PubMed Web of Science ®Google Scholar
• Un K, Kawakami S, Suzuki R, et al. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier. Mol Pharm 2011;8:543–54
   PubMedGoogle Scholar